awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39975103-66304224-EAD5-49CA-A3C0-6FB5DA750594
Q39975103-66304224-EAD5-49CA-A3C0-6FB5DA750594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39975103-66304224-EAD5-49CA-A3C0-6FB5DA750594
Recurrent glioblastoma: who receives tumor specific treatment and how often?
P2860
Q39975103-66304224-EAD5-49CA-A3C0-6FB5DA750594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39975103-66304224-EAD5-49CA-A3C0-6FB5DA750594
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e70a05df1a392bdeb5348bd743efb48af70d366a
P2860
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.